Standard uptake value of positron emission tomography in clinical stage i lung cancer: Clinical application and pathological correlation

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 4, 2012, Pages 868-873

  Huang, Tsai Wang ^a   Hsieh, Chih Ming ^a   Chang, Hung ^a   Cheng, Yeung Leung ^a   Tzao, Ching ^a   Huang, Wen Shen ^a   Lee, Shih Chun ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Lung cancer; PET; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; EPIDEMIOLOGY; LUNG TUMOR; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SCINTISCANNING; TREATMENT OUTCOME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 84862506399     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr113     Document Type: Article

References (24)

1. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The role of FDG-PET scan in staging patients with non small cell carcinoma. Ann Thorac Surg 2003;76:861-6.
2. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017-23.
3. Halpern BS, Schiepers C, Weber WA, Crawford TL, Fueger BJ, Phelps ME et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005;128:2289-97.
4. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005;130:151-9.
5. Davies A, Tan C, Paschalides C, O'Doherty M, Utley M, Treasure T. FDG PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients. Lung Cancer 2007;55:75-8.
6. Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22:3255-60.
7. Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 2002;43: 39-45.
8. Ohtsuka T, Nomori H, Watanabe K, Kaji M, Naruke T, Suemasu K et al. Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. Cancer 2006;107:2468-73.
9. Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP, Wong CY. Revisiting the prognostic value of preoperative 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC). Eur J Nucl Med Mol Imaging 2010; 37:691-8.
10. Jadvar H, Segall GM. False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 1997;38:1382-3.
11. Kim BT, Kim Y, Lee KS, Yoon SB, Cheon EM, Kwon OJ et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. Am J Roentgenol 1998;170:935-9.
12. Goodgame B, Pillot GA, Yang Z, Shriki J, Meyers BF, Zoole J et al. Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer. J Thorac Oncol 2008;3: 130-4.
13. Hanin FX, Lonneux M, Cornet J, Noirhomme P, Coulon C, Distexhe J et al. Prognostic value of FDG uptake in early stage non-small cell lung cancer. Eur J Cardiothorac Surg 2008;33:819-23.
14. Vesselle H, Freeman JD, Wiens L, Stern J, Nguyen HQ, Hawes SE et al. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Clin Cancer Res 2007;13:3255-63.
15. Downey RJ, Akhurst T, Gonen M, Park B, Rusch V. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer. J Thorac Cardiovasc Surg 2007;133:1419-27.
16. Park HK, Jeon K, Koh W-J, Suh GY, Kim H, Kwon OJ et al. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology 2010;15:1179-84.
17. Heo EY, Yang S-C, Yoo C-G, Han SK, Shim YS, Kim YW. Impact of wholebody 18F fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer. Respirology 2010;15: 1174-8.
18. Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg 2008;33: 104-9.
19. Cerfolio RJ, Bryant AS, Eloubeidi MA. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest 2006;130:1791-5.
20. Hellwing AL, Tauson AH, Skrede A. Effect of bacterial protein meal on protein and energy metabolism in growing chickens. Arch Anim Nutr 2006;60:365-81.
21. Al-Sarraf N, Gately K, Lucey J, Lucey J, Wilson L, McGovern E et al. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg 2008;34:892-7.
22. Nair VS, Barnett PG, Ananth L, Gould MK, Veterans Affairs Solitary Nodule Accuracy Project Cooperative Studies Group. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest 2010;137:1150-6.
23. Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ. Prognostic significance of hypoxia-inducible factor-1a, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009;64:1082-9.
24. Tann M, Sandrasegaran K, Winer-Muram HT, Jennings SG, Welling ME, Fletcher JW. Can FDG-PET be used to predict growth of stage I lung cancer? Clin Radiol 2008;63:856-63.